Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2003 2
2007 3
2009 1
2013 3
2014 1
2015 2
2016 3
2017 4
2018 3
2019 4
2020 2
2022 3
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Results by year

Filters applied: . Clear all
Page 1
Comparison of pharmacological inhibitors of lysine-specific demethylase 1 in glioblastoma stem cells reveals inhibitor-specific efficacy profiles.
Stitzlein LM, Gangadharan A, Walsh LM, Nam D, Espejo AB, Singh MM, Patel KH, Lu Y, Su X, Ezhilarasan R, Gumin J, Singh S, Sulman E, Lang FF, Chandra J. Stitzlein LM, et al. Among authors: ezhilarasan r. Front Neurol. 2023 Apr 4;14:1112207. doi: 10.3389/fneur.2023.1112207. eCollection 2023. Front Neurol. 2023. PMID: 37082446 Free PMC article.
PDPN marks a subset of aggressive and radiation-resistant glioblastoma cells.
Modrek AS, Eskilsson E, Ezhilarasan R, Wang Q, Goodman LD, Ding Y, Zhang ZY, Bhat KPL, Le TT, Barthel FP, Tang M, Yang J, Long L, Gumin J, Lang FF, Verhaak RGW, Aldape KD, Sulman EP. Modrek AS, et al. Among authors: ezhilarasan r. Front Oncol. 2022 Aug 10;12:941657. doi: 10.3389/fonc.2022.941657. eCollection 2022. Front Oncol. 2022. PMID: 36059614 Free PMC article.
GPR56/ADGRG1 Inhibits Mesenchymal Differentiation and Radioresistance in Glioblastoma.
Moreno M, Pedrosa L, Paré L, Pineda E, Bejarano L, Martínez J, Balasubramaniyan V, Ezhilarasan R, Kallarackal N, Kim SH, Wang J, Audia A, Conroy S, Marin M, Ribalta T, Pujol T, Herreros A, Tortosa A, Mira H, Alonso MM, Gómez-Manzano C, Graus F, Sulman EP, Piao X, Nakano I, Prat A, Bhat KP, de la Iglesia N. Moreno M, et al. Among authors: ezhilarasan r. Cell Rep. 2017 Nov 21;21(8):2183-2197. doi: 10.1016/j.celrep.2017.10.083. Cell Rep. 2017. PMID: 29166609 Free article.
Ionizing radiation augments glioma tropism of mesenchymal stem cells.
Thomas JG, Parker Kerrigan BC, Hossain A, Gumin J, Shinojima N, Nwajei F, Ezhilarasan R, Love P, Sulman EP, Lang FF. Thomas JG, et al. Among authors: ezhilarasan r. J Neurosurg. 2018 Jan;128(1):287-295. doi: 10.3171/2016.9.JNS16278. Epub 2017 Mar 31. J Neurosurg. 2018. PMID: 28362237 Free PMC article.
Glioblastoma-infiltrated innate immune cells resemble M0 macrophage phenotype.
Gabrusiewicz K, Rodriguez B, Wei J, Hashimoto Y, Healy LM, Maiti SN, Thomas G, Zhou S, Wang Q, Elakkad A, Liebelt BD, Yaghi NK, Ezhilarasan R, Huang N, Weinberg JS, Prabhu SS, Rao G, Sawaya R, Langford LA, Bruner JM, Fuller GN, Bar-Or A, Li W, Colen RR, Curran MA, Bhat KP, Antel JP, Cooper LJ, Sulman EP, Heimberger AB. Gabrusiewicz K, et al. Among authors: ezhilarasan r. JCI Insight. 2016;1(2):e85841. doi: 10.1172/jci.insight.85841. Epub 2016 Feb 25. JCI Insight. 2016. PMID: 26973881 Free PMC article.
ABT-888 restores sensitivity in temozolomide resistant glioma cells and xenografts.
Yuan AL, Ricks CB, Bohm AK, Lun X, Maxwell L, Safdar S, Bukhari S, Gerber A, Sayeed W, Bering EA, Pedersen H, Chan JA, Shen Y, Marra M, Kaplan DR, Mason W, Goodman LD, Ezhilarasan R, Kaufmann AB, Cabral M, Robbins SM, Senger DL, Cahill DP, Sulman EP, Cairncross JG, Blough MD. Yuan AL, et al. Among authors: ezhilarasan r. PLoS One. 2018 Aug 28;13(8):e0202860. doi: 10.1371/journal.pone.0202860. eCollection 2018. PLoS One. 2018. PMID: 30153289 Free PMC article.
30 results